Literature DB >> 33748166

Quercetin Antagonizes Glucose Fluctuation Induced Renal Injury by Inhibiting Aerobic Glycolysis via HIF-1α/miR-210/ISCU/FeS Pathway.

Wei-Long Xu1, Su Liu1, Nan Li1, Li-Fang Ye1, Min Zha1, Chang-Yin Li2, Yue Zhao1, Qiang Pu3, Jin-Jing Bao1, Xing-Jie Chen1, Jiang-Yi Yu1, Ying-Hao Pei4.   

Abstract

Background and Objective: Glucose fluctuation (GF) has been reported to induce renal injury and diabetic nephropathy (DN). However, the mechanism still remains ambiguous. Mitochondrial energy metabolism, especially aerobic glycolysis, has been a hotspot of DN research for decades. The activation of HIF-1α/miR210/ISCU/FeS axis has provided a new explanation for aerobic glycolysis. Our previous studies indicated quercetin as a potential therapeutic drug for DN. This study aims to evaluate levels of aerobic glycolysis and repressive effect of quercetin via HIF-1α/miR210/ISCU/FeS axis in a cell model of GF.
Methods: The mouse glomerular mesangial cells (MCs) were exposed in high or oscillating glucose with or without quercetin treatment. Cell viability was measured by CCK8 assay. Aerobic glycolysis flux was evaluated by lactate acid, pH activity of PFK. Apoptosis level was confirmed by Annexin V-APC/7-AAD double staining and activity of caspase-3. TNF-α and IL-1β were used to evaluate inflammation levels.
Results: GF deteriorated inflammation damage and apoptosis injury in MCs, while quercetin could alleviate this GF-triggered cytotoxicity. GF intensified aerobic glycolysis in MCs and quercetin could inhibit this intensification in a dose-dependent manner. Quercetin prevented activities of two FeS-dependent metabolic enzymes, aconitase, and complex I, under GF injury in MCs. The mRNA expression and protein contents of HIF-1α were increased after GF exposure, and these could be alleviated by quercetin treatment. Knockdown of ISCU by siRNA and Up-regulating of miR-210 by mimic could weaken the effects of quercetin that maintained protein levels of ISCU1/2, improved cell viability, relieved inflammation injury, decreased apoptosis, and reduced aerobic glycolysis switch in MCs.
Conclusion: Quercetin antagonizes GF-induced renal injury by suppressing aerobic glycolysis via HIF-1α/miR-210/ISCU/FeS pathway in MCs cell model. Our findings contribute to a new insight into understanding the mechanism of GF-induced renal injury and protective effects of quercetin.
Copyright © 2021 Xu, Liu, Li, Ye, Zha, Li, Zhao, Pu, Bao, Chen, Yu and Pei.

Entities:  

Keywords:  HIF-1α/miR-210/ISCU/FeS axis; aerobic glycolysis; glucose fluctuation; quercetin; renal injury

Year:  2021        PMID: 33748166      PMCID: PMC7969708          DOI: 10.3389/fmed.2021.656086

Source DB:  PubMed          Journal:  Front Med (Lausanne)        ISSN: 2296-858X


  8 in total

1.  Network Pharmacology-Based Investigation of the Molecular Mechanisms of the Chinese Herbal Formula Shenyi in the Treatment of Diabetic Nephropathy.

Authors:  Keng Chen; Yiyao Deng; Shunlai Shang; Ping Li; Linchang Liu; Xiangmei Chen
Journal:  Front Med (Lausanne)       Date:  2022-06-10

2.  Curcumin Antagonizes Glucose Fluctuation-Induced Renal Injury by Inhibiting Aerobic Glycolysis via the miR-489/LDHA Pathway.

Authors:  Xiaomei Fu; Jianfang Zhang; Xuanjie Huang; Zhifeng Mo; Ziyang Sang; Wenfei Duan; Wenfeng Huang
Journal:  Mediators Inflamm       Date:  2021-08-18       Impact factor: 4.711

3.  Effect of Hemoglobin A1c Trajectories on Future Outcomes in a 10-Year Cohort With Type 2 Diabetes Mellitus.

Authors:  Chifa Ma; Weinan Zhang; Rongrong Xie; Gang Wan; Guangran Yang; Xuelian Zhang; Hanjing Fu; Liangxiang Zhu; Yujie Lv; Jiandong Zhang; Yuling Li; Yu Ji; Dayong Gao; Xueli Cui; Ziming Wang; Yingjun Chen; Shenyuan Yuan; Mingxia Yuan
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-05       Impact factor: 6.055

4.  Exploring the Underlying Mechanism of Shenyankangfu Tablet in the Treatment of Glomerulonephritis Through Network Pharmacology, Machine Learning, Molecular Docking, and Experimental Validation.

Authors:  Meiling Jin; Wenwen Ren; Weiguang Zhang; Linchang Liu; Zhiwei Yin; Diangeng Li
Journal:  Drug Des Devel Ther       Date:  2021-11-09       Impact factor: 4.162

Review 5.  Polyphenols and Their Metabolites in Renal Diseases: An Overview.

Authors:  Íris Guerreiro; Cíntia Ferreira-Pêgo; Diogo Carregosa; Cláudia N Santos; Regina Menezes; Ana S Fernandes; João G Costa
Journal:  Foods       Date:  2022-04-06

Review 6.  Glucose Metabolism in Acute Kidney Injury and Kidney Repair.

Authors:  Lu Wen; Ying Li; Siyao Li; Xiaoru Hu; Qingqing Wei; Zheng Dong
Journal:  Front Med (Lausanne)       Date:  2021-11-29

Review 7.  Metabolic reprogramming: A novel therapeutic target in diabetic kidney disease.

Authors:  Mengdi Wang; Yanyu Pang; Yifan Guo; Lei Tian; Yufei Liu; Cun Shen; Mengchao Liu; Yuan Meng; Zhen Cai; Yuefen Wang; Wenjing Zhao
Journal:  Front Pharmacol       Date:  2022-09-02       Impact factor: 5.988

Review 8.  Mechanism of tonifying-kidney Chinese herbal medicine in the treatment of chronic heart failure.

Authors:  Lizhen Chen; Dayun Yu; Shuang Ling; Jin-Wen Xu
Journal:  Front Cardiovasc Med       Date:  2022-09-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.